QA: Corcept Therapeutics INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2026_Corcept_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001088856, Corcept Therapeutics INC

  xvar xval
0 AssetsCurrent 485,464,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,890,000
3 remainder_Assets 349,297,000
4 LiabilitiesCurrent 166,085,000
5 LiabilitiesNoncurrent 5,023,000
6 remainder_Liabilities 17,738,000
7 CostOfGoodsAndServicesSold 13,889,383
8 SellingGeneralAndAdministrativeExpense 1,289,553,354
9 ResearchAndDevelopmentExpense 253,017,329
10 remainder_Expenses -15,839,962
11 remainder_Revenues 1,005,887,583
12 remainder_NetIncome 19,502,937
13 remainder_ComprehensiveNetIncome -820,287
  yvar yval
0 Assets 836,651,000
1 Liabilities 188,846,000
2 Expenses 1,540,620,104
3 Revenues 1,005,887,583
4 StockholdersEquity 647,805,000
5 NetIncome -515,229,584
6 ComprehensiveNetIncome -515,639,728
7 BaseVar 1,796,163,956
8 EconomicCapitalRatiobeforeLimitedLiability 1.75
9 EconomicCapitalRatio 2.85

Edgar->Model Mapping

Feature Distribution

Change over Time